The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Morrish, E., Wartewig, T., Kratzert, A., Rosenbaum, M., Steiger, K. & Ruland, J. (2022). Eur J Immunol, e2250147.
DOI:10.1002/eji.202250147
